Eun Jeong Cho Selected Research

Hydroxylysine

10/2023	Unleashing the Potential of 1,3-Diketone Analogues as Selective LH2 Inhibitors.
1/2019	Development of a High-Throughput Lysyl Hydroxylase (LH) Assay and Identification of Small-Molecule Inhibitors against LH2.
1/2017	A scalable lysyl hydroxylase 2 expression system and luciferase-based enzymatic activity assay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eun Jeong Cho Research Topics

Disease

19	Neoplasms (Cancer) 01/2024 - 01/2016
3	Breast Neoplasms (Breast Cancer) 01/2017 - 03/2014
2	Parkinson Disease (Parkinson's Disease) 10/2023 - 01/2022
2	Lung Neoplasms (Lung Cancer) 10/2023 - 01/2019
2	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2022
2	Colonic Neoplasms (Colon Cancer) 10/2022 - 10/2022
2	Hypoxia (Hypoxemia) 10/2020 - 01/2016
2	Left Ventricular Dysfunction 06/2017 - 07/2016
2	Human Influenza (Influenza) 04/2012 - 05/2011
1	Nervous System Diseases (Neurological Disorders) 10/2023
1	Stroke (Strokes) 06/2023
1	Hemorrhage 06/2023
1	Myocardial Infarction 06/2023
1	Inflammation (Inflammations) 06/2023
1	Hypertriglyceridemia 11/2022
1	Virus Diseases (Viral Diseases) 11/2022
1	Hypercholesterolemia 10/2022
1	Dyslipidemias (Dyslipidemia) 10/2022
1	Neuroblastoma 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Iron Overload 01/2022
1	Microsatellite Instability 07/2021
1	Body Weight (Weight, Body) 10/2019
1	Atrial Fibrillation 10/2019
1	Mitral Valve Stenosis (Mitral Stenosis) 10/2019
1	Renal Insufficiency (Renal Failure) 10/2019
1	Hypertension (High Blood Pressure) 06/2019
1	Weight Loss (Weight Reduction) 06/2019
1	Stomach Neoplasms (Stomach Cancer) 06/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Genomic Instability 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Mitral Valve Insufficiency (Mitral Regurgitation) 06/2017
1	Heart Valve Diseases (Valvular Heart Disease) 01/2017
1	Triple Negative Breast Neoplasms 01/2017
1	Edema (Dropsy) 12/2016
1	Diarrhea 12/2016
1	Jaundice (Icterus) 12/2016

Drug/Important Bio-Agent (IBA)

3	AldehydesIBA 10/2023 - 01/2017
3	HydroxylysineIBA 10/2023 - 01/2017
3	CollagenIBA 10/2023 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 11/2022 - 05/2011
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2022
2	EnzymesIBA 10/2020 - 01/2016
2	pro-brain natriuretic peptide (1-76)IBA 06/2017 - 01/2017
1	phosphatidylinositol 3,5-diphosphateIBA 01/2024
1	4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA 01/2024
1	SB 203580IBA 01/2024
1	p38 Mitogen-Activated Protein KinasesIBA 01/2024
1	imidazoleIBA 01/2024
1	Dopamine (Intropin)FDA LinkGeneric 10/2023
1	gamma-Aminobutyric Acid (GABA)IBA 10/2023
1	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 10/2023
1	C-Reactive ProteinIBA 06/2023
1	omega-Chloroacetophenone (Mace)IBA 06/2023
1	Indicators and Reagents (Reagents)IBA 06/2023
1	ChemokinesIBA 01/2023
1	CytokinesIBA 01/2023
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2022
1	oxidized low density lipoproteinIBA 10/2022
1	beta-Arrestin 1IBA 10/2022
1	Immune Checkpoint InhibitorsIBA 10/2022
1	Ezetimibe (Zetia)FDA Link 10/2022
1	B7-H1 AntigenIBA 10/2022
1	Hematoxylin (Haematoxylon)IBA 10/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2022
1	pitavastatin (itavastatin)FDA Link 10/2022
1	IronIBA 01/2022
1	CateninsIBA 07/2021
1	Hypoxia-Inducible Factor 1IBA 10/2020
1	edoxabanIBA 10/2019
1	CreatinineIBA 10/2019
1	DiureticsIBA 06/2019
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2019
1	ApolipoproteinsIBA 06/2019
1	Antihypertensive Agents (Antihypertensives)IBA 06/2019
1	HDL CholesterolIBA 06/2019
1	Triglycerides (Triacylglycerol)IBA 06/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	triplex DNA (H-DNA)IBA 01/2019
1	olaparibIBA 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	CrizotinibIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	B-Form DNA (B-DNA)IBA 01/2019
1	Multifunctional EnzymesIBA 01/2018
1	Apyrase (ATP Diphosphatase)IBA 01/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	AntipyreticsIBA 12/2016
1	Blood Glucose (Blood Sugar)IBA 07/2016

Therapy/Procedure

3	Therapeutics 10/2022 - 01/2016
2	Percutaneous Coronary Intervention 06/2023 - 10/2013
1	Gastrectomy 06/2019
1	Renal Dialysis (Hemodialysis) 01/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Catheters 01/2018